Resultado de búsqueda
Hace 19 horas · Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/ Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Hace 6 horas · New Delhi: A Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival outcomes for people in the advanced stages of a rare form of the disease, according to ...
Hace 19 horas · Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma Jun 01 2024 13:00 BST.
Hace 19 horas · NEW YORK (Reuters) – Pfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the strength of data presented on Friday, showing most patients treated for a rare form of advanced lung cancer in a clinical trial were alive without the disease worsening after five years.
Hace 14 horas · Health Innovations and Regulatory Challenges: A Closer Look. This summary highlights key events in the health sector, including the mixed results of Gilead's Trodelvy in cancer trials, Pfizer's optimistic outlook on Lorbrena, US lawmakers' concerns about GenScript Biotech's links to China, and the FDA's scrutiny of MDMA-based PTSD therapy.
Hace 2 horas · GSK Plc and Pfizer Inc. must face about 75,000 Zantac lawsuits filed in state court in Delaware after a judge found the evidence backing up claims that the drugmakers’ former Zantac heartburn treatment causes cancer is legitimate and can be heard by juries.
Hace 19 horas · Today, we will be looking at three dividend stocks that pay huge dividends, all with yields above 5%, one of which is Pfizer (NYSE: PFE). Check out this short video to learn more, consider ...
